ReviewGenes & diseases2026
The role and potential therapeutic intervention of cellular senescence in intervertebral disc degeneration.
Review in Genes & diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deciphering the regulatory mechanism and therapeutic potential of ECM degradation in intervertebral disc degeneration via multi-omics integration.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intervertebral disc degeneration (IDD) is a common cause of low back pain that causes significant debilitation. The intricate mechanisms governing intervertebral disc homeostasis are substantially impacted by cellular senescence, which plays crucial roles in both pathological and physiological contexts. In this review, we provide a comprehensive overview of cellular senescence in the pathogenesis of IDD. Specifically, we summarize the merits and limitations of the methodologies utilized in prior investigations to determine cellular senescence and the potential regulatory mechanisms underlying it in the progression of IDD. Furthermore, we describe therapeutic strategies that aim to inhibit cellular senescence, which may alleviate the pathogenesis of IDD. At last, we discuss the challenges and prospects of translational research on targeting cellular senescence in IDD treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.